Lupin Ltd's anti-cholesterol drug is highly competitive and hence unlikely to contribute significantly to the company, though its getting approval is positive.
New Injectable Class of Anti-Cholesterol Drugs
A new class of anti-cholesterol drugs currently under development in the leading pharmaceutical companies has excited cardiologists
A new class of anti-cholesterol drugs currently under development in the leading pharmaceutical companies has excited cardiologists
According to her, though the drug is highly competitive and hence unlikely to contribute significantly to the company, its getting approval is positive as the approval has come from Lupin's Goa plant, which underwent USFDA audit.
Questions sent to Lupin by IANS remain unacknowledged.
Experimental Anti-Cholesterol Drug Halves the Risk of Heart Attack or Stroke
People taking an experimental drug called evolocumab for high cholesterol were half as likely to die or suffer a heart attack or stroke as those taking conventional statins.
People taking an experimental drug called evolocumab for high cholesterol were half as likely to die or suffer a heart attack or stroke as those taking conventional statins.
Source-IANS
Structural Secrets of Enzyme Used to Make Anti-Cholesterol Drug Revealed
Identifying enzyme catalysts that help improve the speed and efficiency of the process can be a major boon in pharmaceutical production.
Identifying enzyme catalysts that help improve the speed and efficiency of the process can be a major boon in pharmaceutical production.
Britain is the European King of Anti-Cholesterol Drugs
It is perhaps no surprise that Britain is the European king of anti-cholesterol drugs with some seven million users, as the home of cooked breakfasts and pints of beer.
It is perhaps no surprise that Britain is the European king of anti-cholesterol drugs with some seven million users, as the home of cooked breakfasts and pints of beer.
